Preview Mode Links will not work in preview mode

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

Jun 8, 2021

Severe aortic stenosis may go unrecognized, and therefore untreated, in the setting of a low gradient, even if all data point to the existence of a low-flow, low-gradient state and a severe degree of stenosis. In this interview, Mirvat Alasnag, MB, BCH, FACC; Patricia Pellikka, MD, FACC; and Matt Cavender, MD, MPH, FACC,...


May 25, 2021

As HF therapy continues to evolve, barriers like medication cost and non-adherence may impede patient care. Pharmacists can overcome these barriers through collaborative practice agreements and patient and provider education. In this interview, Sean Pinney, MD, FACC; Brad Williams, PharmD; and Nosheen Reza, MD,...


May 18, 2021

The ATLANTIS trial will change the way antithrombotic treatments are chosen after successful transcatheter aortic valve implantation. In this interview, Roxana Mehran, MD, FACC; Jean-Philippe Collet, MD; and Zaid I. Almarzooq, MBBCh, discuss anti-xa oral anticoagulation after valve implantation for aortic stenosis. For 20+...


May 11, 2021

Telemedicine use has surged over the past year, and this may pose a risk to the quality of care if standards aren't applied to its practice and use. In this interview, Alison Bailey, MD, FACC; Jeff Wessler, MD, MPhil, FACC; and Estefania Oliveros, MD, MSc, discuss the challenge of increasing utilization of telemedicine without...


May 4, 2021

In this interview, Spencer King III, MD, MACC; Michael Reardon, MD; and Michelle Kelsey, MD, discuss the natural history of asymptomatic severe aortic stenosis and the association of early intervention with outcomes. For 20+ insider interviews like these every month with CME/MOC credit, subscribe to ACCEL...